- Pilot type 1 hybrid stepped-wedge cluster randomized trial with mixed-methods evaluation, across four Hong Kong emergency departments, in adults with suspected infection and NEWS-2 of 5 or higher.
- NEWS-1 care triggers the Surviving Sepsis Hour-1 Bundle when NEWS-2 is 5 or higher, compared with standard care.
- Lactate, blood culture and antibiotic compliance rose significantly, though overall bundle compliance reached only 56.1%, and the authors judged a full-scale trial feasible with a larger sample.
- Exploratory 30-day mortality did not differ significantly (3.9% vs 9.2%; absolute risk difference 5.3%, 95% CI -1.6% to 12.1%), and adverse events were rare.
Critical care
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Ten pigs were randomised to hypo- or hyperinflammatory ARDS models and imaged with dual-energy CT at individualised PEEP levels in supine and prone positions.
- Hyperinflammatory injury was induced with endotoxin and fluid loading, while hypoinflammatory injury used lung lavage followed by injurious ventilation.
- Hyperinflammatory injury had more severe V/Q mismatch, with normal V/Q at 35% (sd=10) versus 51% (sd=8) for hypoinflammatory injury at low PEEP supine (P<0.01).
- Prone positioning reduced high V/Q and dead space in hypo-inflammatory injury (interaction F1,50=4.32, P=0.04), whereas PEEP reduced low V/Q and shunt supine regardless of subphenotype.
- Secondary analysis of 3000 patients across 21 EPOCH trial centers, covering 4288 urgent ICU consultations grouped into care episodes.
- No intervention was assigned in this analysis; the exposure was whether patients received resuscitation during their first urgent ICU consultation.
- Half of last care episodes ended in urgent ICU admission (49.2%), with 0.1% in-consultation deaths; late escalation was 18% for first and second consultations.
- Among patients with a second consultation, prior resuscitation was linked to more resuscitation events (23.2% vs 3.4%, p<0.01), but late escalation difference was not significant (31.8% vs 15.6%, p=0.07).
- Single-center, randomized, double-blind, placebo-controlled pilot trial of 100 critically ill adults with CAM-ICU-confirmed delirium in surgical and trauma ICUs.
- Patients received 2 mg guanfacine or matching placebo nightly for up to 14 days, or until ICU discharge or delirium resolution.
- Median delirium and coma-free days were 2 (IQR 0-6) with guanfacine versus 1 (IQR 0-4) with placebo (p = 0.02) in unadjusted analyses, but not significant after adjustment.
- Feasibility targets were mostly met, with 100% adherence, retention, and data completeness, though COVID-19 limited recruitment to 0.9 patients/week; authors judge the signal worth a multicenter trial.
AI summary not available. Read the source abstract on PubMed.
- Randomized controlled trial of 100 adults in a general ICU who had received invasive mechanical ventilation for at least 48 hours, comparing music therapy with standard weaning care.
- The music therapy group received daily individualized sessions averaging 25 minutes, including relaxation, music listening, and clinical improvisation, based on patient needs and preferences.
- Weaning duration did not differ between groups (p = 0.97), but agitation and sedation scores improved on days 1 and 3 (p = 0.048, 0.005, 0.024).
- Tracheostomy rates were lower with music therapy (14%; p = 0.025), and the authors suggest it may serve as a complementary adjunct needing further research.
- This multicenter randomized trial enrolled ICU adults meeting HFNC weaning criteria at three tertiary hospitals, with 87 of 102 screened patients completing the trial.
- Patients were randomized to flow reduction first, FiO2 reduction first, or simultaneous reduction of both during HFNC weaning.
- Weaning success was 94%, 81%, and 77% across the groups (p = 0.15), and median weaning duration did not differ (p = 0.87).
- The authors concluded that none of the three HFNC weaning strategies was statistically superior for success or duration.
- Secondary mediation analysis of the A2B randomised trial, with 289 of 1009 surviving patients completing the ICE-Q at 90 days.
- Compared dexmedetomidine, clonidine and propofol sedation on four recalled-experience domains, with mediators including ventilation duration and ICU stay.
- Dexmedetomidine versus propofol was associated with higher awareness of surroundings (median 32 vs 28; adjusted mean difference 3.6, 95% CI 1.0-6.2, p=0.01); clonidine was not significant.
- No other domains showed associations, and the five mediators contributed little; authors call findings hypothesis-generating and advocate personalised sedation.
- Double-blind randomized placebo-controlled trial in 120 mechanically ventilated adults on opioid infusion at two Melbourne ICUs, excluding cardiac surgical patients.
- Patients received low-dose ketamine infusion (0.15 mg/kg/hr) or placebo during mechanical ventilation.
- Median hourly opioid dose was 64 µg/hr with ketamine versus 77 µg/hr with placebo (median difference -13.0, 95% credible interval -26.6 to 2.4; probability of benefit 95.1%).
- Authors concluded low-dose ketamine appeared safe and reduced opioid requirements, while noting that delirium and most other secondary outcomes did not differ and larger trials are needed.
- Randomized controlled trial of 172 patients after elective CABG or valve surgery, allocated to five noninvasive ventilation or high-flow interfaces versus physiotherapy alone in one tertiary ICU.
- Compared a conventional oronasal mask, conventional full-face mask, Wolf Mask, ELMO helmet CPAP, and high-flow nasal cannula, each given three 60-minute daily sessions alongside standard physiotherapy.
- The Wolf Mask had the highest comfort score (9.41 ± 0.68 on a 0-10 VAS) and lowest inspiratory pressure support (5.62 ± 2.08 cmH₂O); interface comfort predicted mobilization progression (p = 0.004).
- The authors conclude full-face interfaces are associated with greater comfort, and they describe the pulmonary and oxygenation findings as exploratory and hypothesis-generating, requiring multicenter confirmation.
- Post hoc secondary analysis of two trials across 30 hospitals, including 1963 adults having major abdominal or thoracic surgery.
- Compared patients given antiemetic-dose intraoperative corticosteroids with those who did not, using inverse probability of treatment weighting for preoperative confounders.
- After weighting, steroids were not significantly associated with fewer postoperative pulmonary complications (OR 0.86, 95% CI 0.62-1.18, P=0.347), though the unweighted rates were lower (9.3% vs 14.0%).
- PACU PaO2/FiO2 ratio was modestly higher with steroids (adjusted mean difference 19.9 mm Hg, 95% CI 0.64-39.1, corrected P=0.043).
- This narrative review critically appraises randomized trial evidence for lung-protective ventilation in patients with ARDS and in those without ARDS.
- Low tidal volumes and titrated PEEP are widely recommended in ARDS, and the review questions whether these strategies also benefit non-ARDS patients.
- The abstract reports that recent trials in non-ARDS patients showed no clear advantage and in some cases suggested potential harm.
- The authors argue that benefit is not consistent across all ARDS patients, favoring ventilator settings individualized to the patient over a uniform approach.
- Prospective documentation by research coordinators in an international stress ulcer prophylaxis trial in invasively ventilated patients, covering 5024 patients or substitute decision-makers approached for consent.
- Consent encounter features (consent model, who requested and gave consent, method) and center characteristics were analyzed with multilevel logistic regression; the trial itself had no intervention for this analysis.
- The overall consent rate was 85.0% (range 27.3% to 100%), with deferred consent associated with higher consent rates (OR 16.56; 95% CI 11.50-23.84).
- Consent rates were also higher when patients themselves were approached (OR 2.67; 95% CI 1.63-4.37) and during or after the COVID-19 pandemic, while center characteristics were not associated.
- Post hoc analysis of a Japanese multicenter RCT in 339 adults aged 65 or older who survived septic shock to 90 days, from 513 eligible patients.
- Frailty at 90 days was graded by Clinical Frailty Scale, and associations with baseline characteristics and treatments were assessed by ordinal regression.
- Higher presepsis CFS (aOR 2.03 per point), higher SOFA (aOR 1.16 per point), and corticosteroid use (aOR 1.72) were each independently associated with more severe frailty.
- Corticosteroid use was linked to frailty mainly in patients already frail at baseline, while SOFA mattered most with lactate of 2 mmol/L or more.
- Multicenter, open-label, cluster-randomized trial of 381 analyzed adults with suspected septic shock managed by prehospital mobile ICU teams in France.
- The 1-hour bundle (antibiotics, up to 35 mL/kg isotonic saline, norepinephrine, and hydrocortisone as needed) was compared with usual care.
- 28-day mortality was 22% (23 of 103) with the bundle versus 27% (76 of 278) with usual care (RR 0.81, 95% CI 0.61-1.08; p = 0.16).
- The authors found no significant mortality reduction and suggest center enrollment imbalances and a small difference in care delivered may explain this.
- Pilot multicenter randomized trial of 35 intubated adults with heatstroke across ten tertiary ICUs in China.
- Compared rapid cooling to 35.0°C held for 48 hours against conventional cooling targeting 36.5–37.5°C, with cooling only above 38.0°C.
- Survival and 28-day poor functional outcome did not differ (17.6% vs 16.7%), but grade 3-4 GI injury (52.9% vs 0%, p<0.001) and arrhythmias (41.2% vs 11.1%, p=0.045) were higher with hypothermia.
- The authors confirmed feasibility for a larger trial and concluded the hypothermia strategy should not be routinely adopted in ICU heatstroke management.
- Prospective randomized physiologic study of 80 patients with early septic shock in one university hospital medical ICU.
- All patients first underwent a 2-hour MAP test (65-70, then 80-85 mm Hg) measuring renal resistive index, then were randomized to low or high MAP targets for 5 days.
- Twenty-three patients (29%) were RRI responders, and among them a higher MAP target did not improve renal outcomes such as diuresis, KDIGO stage, RRT need, or creatinine.
- Nonresponders had higher urine output with the high target, an exploratory finding suggesting that no RRI drop may flag patients who gain diuresis from a higher MAP.
- Secondary analysis of the SISPCT randomized trial, including 971 patients with admission plasma H3.1 data from 33 German ICUs.
- The exposure was admission plasma H3.1 nucleosome levels, and no intervention was assigned in this analysis.
- Each one log10 increase in H3.1 was associated with higher 28-day mortality (adjusted HR 1.48, 95% CI 1.07-2.04; p = 0.02).
- H3.1 levels were also associated with later renal replacement therapy (adjusted HR 1.8, 95% CI 1.34-2.40) and were higher in septic shock than in sepsis.
- A multicenter randomized trial at three hospitals in one Seattle health system enrolled 449 ICU patients and 505 family members, randomizing by patient.
- Nurse communication facilitators supported goal-concordant communication in the ICU and for 3 months afterward, compared with usual control care.
- Family depression on the HADS did not differ between groups over 6 months (difference -0.07, 95% CI -0.70 to 0.55).
- Relationship with the healthcare team (p=0.0162) and goal concordance (p=0.0504) moved in the expected direction, but effect sizes were small.
- Randomized, assessor-blinded trial in 68 tracheostomized adults with neurologic disorders at one rehabilitation department, 34 per group.
- Both groups received airway clearance techniques with conventional treatment for 6 weeks; the experimental group also received abdominal electrical stimulation.
- Decannulation success was 93.3% with stimulation versus 73.3% in controls (OR 5.070, 95% CI 1.41-18.24, p = 0.013), and peak involuntary cough flow was higher (mean difference 39.433 L/min, 95% CI 28.83-50.04, p < 0.001).
- Infection scores and resting diaphragm mobility did not differ between groups, so the authors report benefit for cough, abdominal muscle thickness and decannulation only.
- Randomized crossover trial in 32 mechanically ventilated children aged 1 month to 18 years who completed both 24-hour monitoring phases.
- Continuous automated cuff pressure regulation targeting 15-25 cmH2O was compared with intermittent manual adjustment by bedside nurses under a predefined protocol.
- Low-pressure episodes (<15 cmH2O) occurred in 12.7% with manual monitoring versus 1.3% with automated (p<0.001), and time outside target fell from 118 to 10 hours.
- Nursing workload was lower with automation (0.08 vs 3.65 h), and the authors conclude automated control should be preferred to enhance airway safety.
- Multicenter randomized controlled trial in 172 adult ICU sepsis patients across four hospitals in central China, 86 per arm.
- Early Shenfu injection was compared with normal saline, given at 20 mL/hr over 5 hours, twice daily for three days from sepsis diagnosis.
- Total vasopressor use, measured as norepinephrine equivalents, did not differ significantly between groups (median 22 vs 20; p = 0.16).
- Secondary outcomes showed lower ICU mortality (3.5% vs 11.6%; p = 0.04) and 28-day mortality (15.1% vs 27.9%; p = 0.04), which the authors say needs further validation.
- Post hoc analysis of 70 of 110 severe TBI patients from the BOOST II randomized trial, across ten U.S. ICUs.
- Background electronic ICP data were compared with bedside-identified minimalist episodes (60 minutes or less, tier 1 treatments only), defined as 5 minutes at 20 mm Hg or higher.
- Electronic data confirmed only 47% of 509 bedside-identified episodes, and 76% of the 286 discordant episodes had average electronic ICP below 20 mm Hg.
- The authors conclude bedside identification may not reliably distinguish sustained ICP episodes and propose open-source, real-time, temporally synchronized electronic definitions.
- Secondary analysis of the PROPPR trial, including 286 severely injured patients with complete data out of 680 enrolled across 12 level 1 centers.
- Early emergency department blood draws were analyzed for 48 coagulation and inflammatory biomarkers, grouped into phenotypes using principal component analysis; no intervention was given.
- The 30-day mortality rate was 24.4% (n = 70); after adjustment, the coagulopathy phenotype was associated with mortality (p = 0.0002), and mixed inflammatory phenotype 3 showed a trend (p = 0.0684).
- The authors conclude that coagulation and inflammation are coactivated early after severe injury and are linked to poor outcomes.
- This subgroup analysis of the MINT trial included 3504 adults with acute myocardial infarction and anemia across 144 sites, of whom 1679 (47.9%) were critically ill.
- Patients were randomized to a restrictive strategy (transfuse at hemoglobin below 7-8 g/dL) or a liberal strategy (below 10 g/dL), with 30-day outcomes compared by ICU status.
- The restrictive strategy showed nonsignificant increases in death in critically ill (RR 1.24; 95% CI 0.95-1.61) and noncritically ill patients (RR 1.09; 95% CI 0.77-1.54); interaction p = 0.55.
- Death and death/MI were more common in critically ill patients at 30 days, and the authors found no evidence that the overall liberal-favoring MINT results differ by ICU status.
- Randomized controlled trial in anesthesia residents tested rested and after a 24-hour shift; 35 enrolled, 27 in the primary analysis.
- Sleep-deprived residents were randomized to a 30-minute nap opportunity or control, with actigraphy measuring sleep and nap duration.
- Simulated clinical performance was 14.8 points higher after napping (95% CI 2.8 to 26.9; P = 0.018), while technical skills did not differ significantly.
- The authors conclude napping appears to enhance performance, and exploratory analyses linked longer nap duration to several performance domains.
- Retrospective secondary analysis of a single-center randomized trial in 105 adults undergoing cardiac surgery with signs suggesting endothelial dysfunction.
- All patients received 80 ppm inhaled nitric oxide for 24 hours, then NO was given via cardiopulmonary bypass, mechanical ventilation, or nasal cannula, with metHb and uptake compared across these methods.
- Median metHb was 0.6% on bypass, 2.1% on ventilation, and 0.8% on nasal cannula; the metHb rise slope was steeper on ventilation than on bypass (β 8.354 * 10-3 vs 3.738 * 10-3, p < 0.001).
- Estimated NO delivery was higher on ventilation than on bypass (median 25.1 vs 8.2 μmol/min, p < 0.001), and the authors suggest metHb may help guide therapy when extrapulmonary effects are desired.
- Secondary analysis of the multicenter randomized FACTT trial of conservative fluid management in ARDS, using plasma sST2 (n = 826) and IL-6 (n = 755).
- Exposure was day 0 and day 3 plasma concentrations of sST2 and IL-6, analyzed against extubation timing, weaning assessments, and reintubation.
- Higher day 3 sST2 was associated with lower probability of extubation (HR 0.64; 95% CI 0.54-0.75; p < 0.0001), and higher IL-6 showed a similar pattern.
- Higher sST2 and IL-6 were also linked to higher odds of reintubation (sST2 OR 3.23; 95% CI 1.04-10.07; IL-6 OR 2.58; 95% CI 1.14-5.84), and the authors suggest biomarker-directed ventilator management may help.
- Secondary analysis of 931 patients with acute lung injury from a randomized fluid-liberal versus fluid-conservative trial, measuring angiopoietin-2 and von Willebrand factor.
- Angiopoietin-2 and von Willebrand factor were examined against mortality, stratified by infection versus noninfection risk factor and by fluid strategy.
- In noninfection-related injury, higher baseline angiopoietin-2 was associated with mortality (OR 2.43 per log increase; 95% CI 1.57-3.75; p < .001).
- In infection-related injury, rising angiopoietin-2 from day 0 to day 3 carried OR 2.29 for death (95% CI 1.54-3.43), and conservative fluids lowered it 15% more (95% CI 4.6-24.8%; p = .006).
- Secondary analysis of a single-center randomized pilot trial (EDEN) including 175 medical ICU patients with acute respiratory failure.
- Exposure was plasma adiponectin measured within 48 hours of respiratory failure, with no intervention applied.
- Higher early adiponectin was associated with 28-day mortality (OR 1.59 per 5 μg/mL; 95% CI 1.15-2.21; p=.006).
- Adiponectin rose by day 6 only in survivors, and the authors suggest adipose-derived factors may modulate the critical illness response.
- Randomized laboratory study in male Sprague Dawley rats (270 to 330 g) at a university research lab, comparing resuscitation with mesenteric venous hypertension using normal saline versus hypertonic saline.
- Intervention was 80 mL/kg hypertonic saline added to normal saline resuscitation, compared against normal saline alone, with edema, fluid volumes, hydraulic conductivity, and aquaporin measurements after 6 hours.
- Hypertonic saline decreased intestinal edema and increased urine, intraluminal, and peritoneal fluid volume, with increased hydraulic conductivity at mucosal and seromuscular surfaces; no effect sizes or p values are reported in the abstract.
- The authors conclude that hypertonic saline reduces edema through increased membrane conductivity, linked to aquaporin 4 up-regulation, and suggest aquaporin 4 as a possible therapeutic target.
- Randomized controlled animal study in adult male C57BL/6 mice, comparing control diet, zinc-deficient diet, and zinc repletion before cecal ligation and puncture.
- Zinc-deficient mice were compared with control-diet mice under polymicrobial sepsis induced by CLP, with sham-operated mice as additional controls.
- Sepsis mortality was 90% with zinc deficiency versus 30% on control diet, and deficient CLP mice had higher cytokines and more organ injury, especially lungs and spleen.
- Zinc supplementation normalized inflammation and reduced tissue damage and mortality, but the authors describe the protection as incomplete.
- A single-center pediatric ICU study with an observational cohort of 37 children with multiorgan dysfunction, followed by a small randomized trial.
- In the trial, children with severe TAMOF were randomized to intensive plasma exchange or standard therapy.
- Children with TAMOF had lower ADAMTS-13 activity than children with MOF without thrombocytopenia (p<0.05), and all non-survivors had VWF-rich microvascular thromboses at autopsy.
- Plasma exchange restored ADAMTS-13 activity and organ function versus standard therapy in the randomized patients, reported only as p<0.05.